Literature DB >> 18757527

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.

Monica Ter-Minassian1, Rihong Zhai, Kofi Asomaning, Li Su, Wei Zhou, Geoffrey Liu, Rebecca Suk Heist, Thomas J Lynch, John C Wain, Xihong Lin, Immaculata De Vivo, David C Christiani.   

Abstract

Apoptosis is important for targeting cancer cells for destruction. Various single-nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS -1377 G>A (rs2234767), FASLG -844 C>T (rs763110), IL1B +3954 C>T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). We studied the association of these SNPs with non-small cell lung cancer (NSCLC) in a large case-control study (N = 4263: 2644 cases and 1619 controls). No associations with NSCLC were observed in the main effects analysis for all four SNPs, adjusting for age, gender, smoking status, pack-years and years since smoking cessation. In subjects under age 60, for FASLG -844 C>T polymorphism, CT compared with the CC genotype, was significantly associated with increased risk of NSCLC, adjusted odds ratio (aOR) = 1.58 (1.22, 2.05), P = 0.0006 and TT aOR = 1.45 (1.01, 2.04), P = 0.04. In contrast, for those over age 60, the CT aOR = 0.91 (0.73, 1.13), P = 0.37 and TT aOR = 0.86 (0.64, 1.16), P = 0.32. The P-value for the age-genotype interaction was 0.004. For the IL1B +3954 C>T polymorphism, compared with the CC genotype, TT showed significant associations in former smokers and in men but tests of interaction were not significant (P(smoking) = 0.24, P(gender) = 0.17). No interactions were observed for FAS -1377 G>A and BAT3 Ser625Pro polymorphisms. Our findings indicate that age and smoking may modify the association of the FASLG -844 and IL1B + 3954 SNPs with the risk of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757527      PMCID: PMC2577138          DOI: 10.1093/carcin/bgn205

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  39 in total

1.  Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Authors:  David P Miller; Geoffrey Liu; Immaculata De Vivo; Thomas J Lynch; John C Wain; Li Su; David C Christiani
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

2.  Adenocarcinoma of the lung is strongly associated with cigarette smoking: further evidence from a prospective study of women.

Authors:  P Yang; J R Cerhan; R A Vierkant; J E Olson; C M Vachon; P J Limburg; A S Parker; K E Anderson; T A Sellers
Journal:  Am J Epidemiol       Date:  2002-12-15       Impact factor: 4.897

3.  The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.

Authors:  W Zhou; S W Thurston; G Liu; L L Xu; D P Miller; J C Wain; T J Lynch; L Su; D C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

Review 4.  Apoptosis and lung cancer: a review.

Authors:  Narayan Shivapurkar; Jyotsna Reddy; Preet M Chaudhary; Adi F Gazdar
Journal:  J Cell Biochem       Date:  2003-04-01       Impact factor: 4.429

5.  Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.

Authors:  Tong Sun; Xiaoping Miao; Xuemei Zhang; Wen Tan; Ping Xiong; Dongxin Lin
Journal:  J Natl Cancer Inst       Date:  2004-07-07       Impact factor: 13.506

6.  Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis.

Authors:  S A Khuder
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

7.  A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients.

Authors:  Jianming Wu; Christine Metz; Xiulong Xu; Riichiro Abe; Andrew W Gibson; Jeffrey C Edberg; Jennifer Cooke; Fenglong Xie; Glinda S Cooper; Robert P Kimberly
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein.

Authors:  Stephanie K Hall; David G Perregaux; Christopher A Gabel; Thasia Woodworth; L Kathryn Durham; T W F Huizinga; F C Breedveld; Albert B Seymour
Journal:  Arthritis Rheum       Date:  2004-06

9.  Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer.

Authors:  Shanbeh Zienolddiny; David Ryberg; Valentina Maggini; Vidar Skaug; Federico Canzian; Aage Haugen
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

10.  Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Authors:  Kathryn Sibley; Sara Rollinson; James M Allan; Alexandra G Smith; Graham R Law; Philippa L Roddam; Christine F Skibola; Martyn T Smith; Gareth J Morgan
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  30 in total

1.  Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Authors:  Jie Lin; Charles Lu; David J Stewart; Jian Gu; Maosheng Huang; David W Chang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

2.  FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls.

Authors:  Li-Xin Qiu; Jian Shi; Hui Yuan; Xin Jiang; Kai Xue; Hai-Feng Pan; Jin Li; Ming-Hua Zheng
Journal:  Hum Genet       Date:  2009-02-19       Impact factor: 4.132

3.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

4.  BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.

Authors:  Jiquan Chen; Yuan-Sheng Zang; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-07-04

5.  Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.

Authors:  Rihong Zhai; Feng Chen; Geoffrey Liu; Li Su; Matthew H Kulke; Kofi Asomaning; Xihong Lin; Rebecca S Heist; Norman S Nishioka; Chau-Chyun Sheu; John C Wain; David C Christiani
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

6.  Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.

Authors:  Gudrun Knechtel; Günter Hofmann; Armin Gerger; Wilfried Renner; Tanja Langsenlehner; Joanna Szkandera; Gerald Wolf; Hellmut Samonigg; Peter Krippl; Uwe Langsenlehner
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-05       Impact factor: 4.553

7.  Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study.

Authors:  Sheng Wei; Jiangong Niu; Hui Zhao; Zhensheng Liu; Li-E Wang; Younghun Han; Wei V Chen; Christopher I Amos; Thorunn Rafnar; Patrick Sulem; Kari Stefansson; Maria T Landi; Neil E Caporaso; Demetrius Albanes; Michael J Thun; James D McKay; Paul Brennan; Yufei Wang; Richard S Houlston; Margaret R Spitz; Qingyi Wei
Journal:  Carcinogenesis       Date:  2011-02-02       Impact factor: 4.944

8.  Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer.

Authors:  Mary E Cooley; Karen M Emmons; Robert Haddad; Qian Wang; Marshall Posner; Raphael Bueno; Tiffany-Jen Cohen; Bruce E Johnson
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

9.  Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer.

Authors:  C Matthew Kinsey; Raul San José Estépar; Jos van der Velden; Bernard F Cole; David C Christiani; George R Washko
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-19       Impact factor: 4.254

10.  Association of vitamin D receptor FokI and ApaI polymorphisms with lung cancer risk in Tunisian population.

Authors:  Wajih Kaabachi; Safa Kaabachi; Ahlem Rafrafi; Amira Ben Amor; Kalthoum Tizaoui; Faycal Haj Sassi; Kamel Hamzaoui
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.